Article
No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population.
Psychiatric genetics - 1 Dec 2005
Ham Byung-Joo, Lee Min-Soo, Lee Heon-Jeong, Kang Rhee-Hun, Han Chang-Su, Choi Myoung-Jin, Lee Seung-Hwan, Ryu Seung-Ho
Abstract excerpt
The serotonergic neurotransmitter system has been implicated in major depressive disorder (MDD) and appears to be the target of a variety of antidepressants. Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in serotonin biosynthesis, and selective serotonin re-uptake inhibitors exert their activity enhancing the general serotonergic tone. The goal of this study was to investigate whether the A218C...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
